Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 17Radiotherapy 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Fluorouracil 7Magnetic Resonance Spectroscopy 6Docetaxel 6Platinum 5Gemcitabine 51,2-diaminocyclohexaneplatinum II citrate 5Paclitaxel 4Specimen Handling 3Radiation 3Drug Therapy 3Cetuximab 3Carboplatin 3(225)Ac-DOTA-c(RGDyK) 3atezolizumab 2Iodine-123 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Disulfides 2Biopsy 2trametinib 1toripalimab 1ponatinib 1pertuzumab 1nimotuzumab 1fosbretabulin 1fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × alfacalcidol × Head & Neck × Clear all
NCT06016400 2023-08-29

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2/3 Unknown
412 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡